[1]章晓燕,王 薇,王治国.基于西格玛度量优化临床检验风险分析质量控制计划[J].现代检验医学杂志,2016,31(04):154-156,158.[doi:10.3969/j.issn.1671-7414.2016.04.045]
　ZHANG Xiao-yan,WANG Wei,WANG Zhi-guo.Prioritizing Risk Analysis Quality Control Plan Based on Sigma-Metrics[J].Journal of Modern Laboratory Medicine,2016,31(04):154-156,158.[doi:10.3969/j.issn.1671-7414.2016.04.045]
点击复制

基于西格玛度量优化临床检验风险分析质量控制计划()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年04期
页码:
154-156,158
栏目:
质量控制·实验室管理
出版日期:
2016-08-10

文章信息/Info

Title:
Prioritizing Risk Analysis Quality Control Plan Based on Sigma-Metrics
文章编号:
1671-7414(2016)04-154-04
作者:
章晓燕; 王 薇; 王治国
北京医院卫生部临床检验中心,北京 100730
Author(s):
ZHANG Xiao-yan; WANG Wei; WANG Zhi-guo
National Center for Clinical Laboratories,Beijing Hospital,Beijing 100730,China
关键词:
六西格玛;  西格玛度量;  风险管理;  故障模式和效应分析;  质量控制计划
分类号:
R446
DOI:
10.3969/j.issn.1671-7414.2016.04.045
文献标志码:
A
摘要:
六西格玛(6σ)是一种允许对过程性能进行客观评估的技术,可用σ度量量化分析检测过程的性能和风险。EP23A为实验室提供了可选择的多种风险评估技术,以设计个性化的质量控制计划。方法决定图是区分σ性能的工具,使用方法性能数据产生可接受性的直观评估,而操作规范图是基于σ性能确定试验所要求质量控制的直观工具。故障模式和效应分析(FMEA)是风险评估中常用的一种技术,可用于观察医疗实施过程中的关键弱点。合理使用6σ质量控制设计工具能促进FMEA,风险评估过程和QC计划的设计。
Abstract:
Six sigma is a technique that allows objective assessment of process performance. The sigma-metric quantifies the performanceand the risk of an analytical testing process.EP23A empowers the laboratory tochoose among many risk assessment techniques to design an individualized quality control plan.The method decision chart is a visual tool that differentiates sigma performance,using data on method performance to generate a visual assessment of acceptability.And the operating specifications chart is a visual tool that identifies the quality control(QC)required by a test,based on sigma performance.Failure mode and effects analysis(FMEA),a technique commonly used in risk assessment,has been observed to exhibit key weaknesses in health care implementations.The rational use of the six sigma QC design tools can enhance FMEA,the risk assessment process,and design of QC plan.

参考文献/References:

[1] CLSI EP23-A.Laboratory quality control based on r-isk management; approved guideline[S].Wayne:PA,Clinical and Laboratory Standards Institute EP23-A,2011.
[2] Nichols JH.Laboratory quality control based on risk management[J].AnnSaudi Med,2011,31(3):223-228.
[3] CLIA Individualized Quality Control Plan(IQCP)be-nefits[EB/OL].http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/Downloads/IQCPbenefits.pdf,2012.
[4] 王治国.临床检验6σ质量控制设计与控制[M].北京:人民卫生出版社,2012. Wang ZG.Six sigma quality design and control in clinical laboratory[M].Beijing:People's Medical Publishing House,2012.
[5] Nevalainen D,Berte L,Kraft C,et al.Evaluating laboratory performanceon quality indicators with the Six Sigma scale[J].Arch Pathol Lab Med,2000,124(4):516-519.
[6] Llopis MA,Trujillo G,Llovet MI,et al.Quality Indicators and specifications for key analytical-extraanalytical processes in the clinical laboratory.Five years' experience using the Six Sigma concept[J].Clin Chem Lab Med,2011,49(3):463-470.
[7] 康凤凤,王治国.临床实验室质量控制中的风险管理[J].临床检验杂志,2012,30(7):539-542. Kang FF,Wang ZG.Risk management for quality co-ntrol in clinicallaboratory[J].Clin J Clin Lab Sci,2012,30(7):539-542.
[8] 费 阳,王 薇,王治国.临床检验室内质量控制规则设计新工具-Westgard西格玛规则[J].现代检验医学杂志,2015,30(1):149-152. Fei Y,Wang W,Wang ZG.A new internal quality control rules designtool in clinical laboratory- Westgard sigma rules[J].J Mod Lab Med,2015,30(1):149-152.
[9] Westgard JO,Carey RN,Wold S.Criteria for judging precision and accuracy in method development and evaluation[J].Clin Chem,1974,20(7):825-833.
[10] 王治国.临床检验质量控制技术[M].3版.北京:人民卫生出版社,2014. Wang ZG.Quality control technology in clinical laboratory[M].3th Ed.Beijing:People's Medical Publishing House,2014.
[11] 肖亚玲,王 薇,王治国.心肌损伤标志物四项检测性能的西格玛水平分析[J].现代检验医学杂志,2014,29(1):38-41. Xiao YL,Wang W,Wang ZG.Performance analysis of four myocardial damage markers testing with sigma level[J].J Mod Lab Med,2014,29(1):38-41.
[12] Westgard SA,Salcedo G.A Six Sigma risk analysis example: defining QCfrequency with FMEA.July 2012[EB/OL].http://www.westgard.com/ endoclab-risk.htm.Accessed September,2012.

相似文献/References:

[1]程秀丽,王 琴,李 巍,等.Westgard西格玛多规则方法在临床血液学检验常规项目质控中的应用[J].现代检验医学杂志,2018,33(05):151.[doi:10.3969/j.issn.1671-7414.2018.05.042]
　CHENG Xiu-li,WANG Qin,LI Wei,et al.Application of Westgard Sigma Rules in Routine Clinical Hematology Tests[J].Journal of Modern Laboratory Medicine,2018,33(04):151.[doi:10.3969/j.issn.1671-7414.2018.05.042]
[2]刘彦明,何坤,刘熙君,等.6σ理论在激素类项目检验质量精益管理中的应用[J].现代检验医学杂志,2019,34(01):148.[doi:10.3969/j.issn.1671-7414.2019.01.039]
　LIU Yan-ming,HE Kun,LIU Xi-jun,et al.Application of 6 σ Theory for Quality Promotion in the Detection of Endocrinology Project Inspection[J].Journal of Modern Laboratory Medicine,2019,34(04):148.[doi:10.3969/j.issn.1671-7414.2019.01.039]
[3]王 辉,徐克和,唐书强,等.临床化学实验室质量控制计算实际西格玛值的新方法[J].现代检验医学杂志,2019,34(02):132.[doi:10.3969/j.issn.1671-7414.2019.02.034]
　WANG Hui,XU Ke-he,TANG Shu-qiang,et al.New Method for Calculating the Actual Sigma Metricsin Clinical Chemistry Laboratory Quality Control[J].Journal of Modern Laboratory Medicine,2019,34(04):132.[doi:10.3969/j.issn.1671-7414.2019.02.034]
[4]闫玉珠,王冀邯,赵和平.六西格玛质量管理规则在罗氏电化学发光免疫分析仪检测项目质量控制中的应用[J].现代检验医学杂志,2020,35(02):149.[doi:10.3969/j.issn.1671-7414.2020.02.041]
　YAN Yu-zhu,WANG Ji-han,ZHAO He-ping.Six Sigma Quality Management for Choosing Appropriate Quality ControlRules in Roche Electrochemical Luminescence Immunoanalyzer[J].Journal of Modern Laboratory Medicine,2020,35(04):149.[doi:10.3969/j.issn.1671-7414.2020.02.041]
[5]张楠楠a,李淮淮b,王绪山a.6σ 质量管理在凝血酶原时间室间质量评价与室内质量控制分析应用[J].现代检验医学杂志,2020,35(03):149.[doi:10.3969/j.issn.1671-7414.2020.03.040]
　ZHANG Nan-nana,LI Huai-huaib,WANG Xu-shana.Application of 6 σ Theory on Prothrombin Time Quality Management Through the Data from External Quality Assessment and Internal Quality Control[J].Journal of Modern Laboratory Medicine,2020,35(04):149.[doi:10.3969/j.issn.1671-7414.2020.03.040]

备注/Memo

备注/Memo:

作者简介:章晓燕(1992-),女,硕士研究生,研究方向:实验室质量管理,E-mail:553434613@qq.com。
通讯作者:王治国,研究员,E-mail:zgwang@nccl.org.cn。
更新日期/Last Update: 2016-08-10